Skip to main navigation
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Denmark
Ecuador
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Indonesia
Ireland
Italy
Japan
Korea
Latin America
Malaysia
Mexico
Netherlands
Norway
Pakistan
Peru
Philippines
Russia
Singapore
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
United Kingdom
Venezuela
Vietnam
Lilly
  • Who We Are
    • Lilly for Better
    • Governance
      • Board of Directors
      • Executive Committee
    • Business Areas
      • Bio-Medicines
      • Diabetes
      • Oncology
      • International
      • Elanco Animal Health
    • Key Issues
      • Biosimilars
      • Health Care Reform
      • Intellectual Property
      • Trade
      • U.S. Tax Reform
      • Value-Based Pricing
    • Diversity & Inclusion
      • Diversity in Clinical Trials
      • People and Partnerships
      • Supplier Diversity
    • Lilly Foundation
    • Grant Office
  • Caring
    • Advancing Medical Science
    • Improving Global Health
      • Hunger
      • Patient Programs
    • Strengthening Communities
      • Education
      • Giving
      • Volunteering
    • Operating Responsibly
      • Ethics and Compliance Program
      • Transparency
  • Discovery
    • Clinical Development Pipeline
    • R&D Partnering
    • Clinical Trials
      • Clinical Trials Transparency
      • Expanded Access
    • Research Ethics
  • Products
    • Historic Products
    • HCP Medical Information
    • Patient Safety
      • Patient's Role
      • Provider's Role
      • FDA's Role
      • Lilly's Role
    • Anti-Counterfeiting
    • Making Safe, High-Quality Medicine
  • Careers
  • Investors
    • Webcasts & Presentations
    • Financials
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Interactive Financials
      • Debt Securities
    • Stock Info
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Dividends & Stock Splits
    • Individual Investors
    • Shareholder Tools & Resources
      • Email Alerts
      • RSS News Feeds
  • Partners
    • Scientific Areas of Interest
    • Scientific Partnering
  • Newsroom
    • Media Contacts
    • Social Channels
      • Facebook
      • Twitter
      • Instagram
      • LinkedIn
    • Blogs
    • RSS News Feeds
    • Press Releases
      • Press Release Archives
  • Home
  • Investors
  • 2019 Guidance Call

2019 Guidance and Investor Update

Dec 19, 2018 at 9:00 AM EST

Add to Outlook
Add to Google Calendar
Lilly
  • Privacy Statement
  • Terms of Use
  • Diversity
  • Suppliers
  • Login
  • Sitemap
  • Contact

Copyright © 2018 Eli Lilly and Company. All rights reserved.